Innovation Theater Lunch (non-accredited/non-approved for CECH): Expand the Knowledge of Molecular Pathways in the Healing of Chronic Skin Wounds

Sponsored by EnColl Corporation

Chronic skin wounds are resulted from varied conditions such as diabetes, venous insufficiency, physical pressure, or neural impairment. Despite advances in wound care, the molecular mechanisms driving chronic wound healing remain insufficiently understood. This innovation theatre aims to delve into the significance of most biocompatible matrix for the best clinical outcome. Further, the objective is to explore the intricate molecular pathways that influence the healing process in chronic skin wounds, focusing on the roles of inflammation, cellular signaling, and tissue regeneration. The role of collagen phosphorylation in cell signalling is one of the key physiological event yet to be understood and will be explored in depth. By expanding our understanding of these pathways, we aim to uncover novel therapeutic targets and intervention strategies that can accelerate wound healing, enhance tissue regeneration, and improve patient outcomes. Attendees will gain insights into cutting-edge research, technological advancements, and clinical applications, fostering collaboration and driving innovation in the treatment of chronic skin wounds.